Literature DB >> 18227261

A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli.

Christina Bronowski1, Shirley L Smith, Kyoko Yokota, John E Corkill, Helen M Martin, Barry J Campbell, Jonathan M Rhodes, C Anthony Hart, Craig Winstanley.   

Abstract

Adherent and invasive mucosa-associated Escherichia coli have been implicated in the pathogenesis of colon cancer and inflammatory bowel diseases. It has been reported that such isolates share features of extraintestinal E. coli (ExPEC) and particularly uropathogenic E. coli (UPEC). We used suppression subtractive hybridization (SSH) to subtract the genome of E. coli K-12 from that of a colon cancer mucosal E. coli isolate. Of the subtracted sequences, 53 % were present in the genomes of one or more of three sequenced UPEC strains but absent from the genome of an enterohaemorrhagic E. coli (EHEC) strain. Of the subtracted sequences, 80 % matched at least one UPEC genome, whereas only 4 % were absent from the UPEC genomes but present in the genome of the EHEC strain. A further genomic subtraction against the UPEC strain 536 enriched for sequences matching mobile genetic elements, other ExPEC strains, and other UPEC strains or commensals, rather than strains associated with gastrointestinal disease. We analysed the distribution of selected subtracted sequences and UPEC-associated pathogenicity islands (PAIs) amongst a panel of mucosa-associated E. coli isolated from colonoscopic biopsies of patients with colon cancer, patients with Crohn's disease and controls. This enabled us to identify a group of isolates from colon cancer (30-40 %) carrying multiple genes previously categorized as UPEC-specific and implicated in virulence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227261     DOI: 10.1099/mic.0.2007/013086-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  13 in total

Review 1.  Questions and challenges associated with studying the microbiome of the urinary tract.

Authors:  Yige Bao; Kait F Al; Ryan M Chanyi; Samantha Whiteside; Malcom Dewar; Hassan Razvi; Gregor Reid; Jeremy P Burton
Journal:  Ann Transl Med       Date:  2017-01

2.  Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82.

Authors:  Sylvie Miquel; Eric Peyretaillade; Laurent Claret; Amélie de Vallée; Carole Dossat; Benoit Vacherie; El Hajji Zineb; Beatrice Segurens; Valerie Barbe; Pierre Sauvanet; Christel Neut; Jean-Frédéric Colombel; Claudine Medigue; Francisco J M Mojica; Pierre Peyret; Richard Bonnet; Arlette Darfeuille-Michaud
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

3.  Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains.

Authors:  Margarita Martinez-Medina; Azucena Mora; Miguel Blanco; Cecilia López; María Pilar Alonso; Stéphane Bonacorsi; Marie-Hélène Nicolas-Chanoine; Arlette Darfeuille-Michaud; Jesus Garcia-Gil; Jorge Blanco
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

4.  Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae.

Authors:  Johannes Putze; Claire Hennequin; Jean-Philippe Nougayrède; Wenlan Zhang; Stefan Homburg; Helge Karch; Marie-Agnés Bringer; Corinne Fayolle; Elisabeth Carniel; Wolfgang Rabsch; Tobias A Oelschlaeger; Eric Oswald; Christiane Forestier; Jörg Hacker; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

5.  Case-control study of vitamin D, dickkopf homolog 1 (DKK1) gene methylation, VDR gene polymorphism and the risk of colon adenoma in African Americans.

Authors:  Hassan Ashktorab; Bijou Nguza; Mehrnaz Fatemi; Mehdi Nouraie; Duane T Smoot; Alejandro A Schäffer; Sonia S Kupfer; Carlos A Camargo; Hassan Brim
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

6.  Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease.

Authors:  Rebecca Munk Vejborg; Viktoria Hancock; Andreas M Petersen; Karen A Krogfelt; Per Klemm
Journal:  BMC Genomics       Date:  2011-06-15       Impact factor: 3.969

7.  Escherichia coli, an Intestinal Microorganism, as a Biosensor for Quantification of Amino Acid Bioavailability.

Authors:  Vesela I Chalova; Sujata A Sirsat; Corliss A O'Bryan; Philip G Crandall; Steven C Ricke
Journal:  Sensors (Basel)       Date:  2009-09-04       Impact factor: 3.576

Review 8.  Gut microbiota and colorectal cancer.

Authors:  R Gao; Z Gao; L Huang; H Qin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-07       Impact factor: 3.267

9.  High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer.

Authors:  Emmanuel Buc; Damien Dubois; Pierre Sauvanet; Jennifer Raisch; Julien Delmas; Arlette Darfeuille-Michaud; Denis Pezet; Richard Bonnet
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line.

Authors:  Xuan He; Darya O Mishchuk; Jigna Shah; Bart C Weimer; Carolyn M Slupsky
Journal:  Sci Rep       Date:  2013-12-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.